每經(jing)AI快訊，有投(tou)資者在投(tou)資者互動平(ping)臺提問(wen)：請(qing)問(wen)，公司主線獸藥(yao)（西(xi)藥(yao)）國家主推的(de)無抗(kang)養殖保健(jian)，生(sheng)豬暫時(shi)不太嚴(yan)格，以蛋禽為例獸藥(yao)使用量(liang)已經(jing)縮減，后期生(sheng)豬也(ye)可能會(hui)持續嚴(yan)查抗(kang)生(sheng)素，募(mu)投(tou)的(de)錢有做無抗(kang)養殖保健(jian)投(tou)入(ru)嗎，或未來有涉及和(he)加大投(tou)資占(zhan)比嗎！以及今年10月以來北方豬瘟對公司四季度藥(yao)物出貨量(liang)影響有多(duo)少

回盛生(sheng)(sheng)物(wu)(wu)（300871.SZ）12月(yue)7日在(zai)(zai)投(tou)(tou)資者互動(dong)(dong)(dong)平臺表示，禁抗(kang)(kang)(kang)(kang)的(de)內(nei)涵可以理解為“飼料(liao)端禁抗(kang)(kang)(kang)(kang)，養殖(zhi)端限抗(kang)(kang)(kang)(kang)，食品(pin)(pin)(pin)端無抗(kang)(kang)(kang)(kang)”，從歐盟禁抗(kang)(kang)(kang)(kang)結果來看，抗(kang)(kang)(kang)(kang)生(sheng)(sheng)素仍是動(dong)(dong)(dong)物(wu)(wu)防疫的(de)重要手(shou)段(duan)。在(zai)(zai)飼料(liao)中(zhong)(zhong)(zhong)禁止(zhi)使用(yong)(yong)抗(kang)(kang)(kang)(kang)生(sheng)(sheng)素，現場(chang)臨床用(yong)(yong)藥(yao)(yao)(yao)(yao)會增(zeng)加。養殖(zhi)端限抗(kang)(kang)(kang)(kang)和食品(pin)(pin)(pin)端無抗(kang)(kang)(kang)(kang)將推動(dong)(dong)(dong)養殖(zhi)行業更加注(zhu)重使用(yong)(yong)高質量動(dong)(dong)(dong)保(bao)產(chan)(chan)品(pin)(pin)(pin)。中(zhong)(zhong)(zhong)獸(shou)藥(yao)(yao)(yao)(yao)因其具備藥(yao)(yao)(yao)(yao)物(wu)(wu)無殘留的(de)特點，是調(diao)節(jie)(jie)免(mian)(mian)疫、防控(kong)病毒性(xing)疫病的(de)有(you)(you)效(xiao)手(shou)段(duan)，公(gong)(gong)司(si)(si)重視中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)制劑領域新產(chan)(chan)品(pin)(pin)(pin)的(de)研發(fa)，設(she)有(you)(you)中(zhong)(zhong)(zhong)獸(shou)藥(yao)(yao)(yao)(yao)研究所，已有(you)(you)茯苓多(duo)糖散（衛(wei)免(mian)(mian)）、板青顆粒、甘草(cao)顆粒等(deng)(deng)中(zhong)(zhong)(zhong)獸(shou)藥(yao)(yao)(yao)(yao)產(chan)(chan)品(pin)(pin)(pin)在(zai)(zai)售，在(zai)(zai)動(dong)(dong)(dong)物(wu)(wu)免(mian)(mian)疫調(diao)節(jie)(jie)、清熱解毒及促生(sheng)(sheng)長(chang)等(deng)(deng)方(fang)面具有(you)(you)較好效(xiao)果，如(ru)茯苓多(duo)糖散是由(you)茯苓經提(ti)取(qu)加工精制而成(cheng)的(de)中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)散劑，具有(you)(you)增(zeng)強免(mian)(mian)疫的(de)功效(xiao)，主要用(yong)(yong)于提(ti)高豬對(dui)豬瘟疫苗和豬偽狂(kuang)犬病疫苗等(deng)(deng)的(de)免(mian)(mian)疫應(ying)答。目前，公(gong)(gong)司(si)(si)募投(tou)(tou)項(xiang)目“中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)提(ti)取(qu)及制劑生(sheng)(sheng)產(chan)(chan)線建設(she)項(xiang)目”已建成(cheng)投(tou)(tou)產(chan)(chan)，提(ti)升了公(gong)(gong)司(si)(si)中(zhong)(zhong)(zhong)獸(shou)藥(yao)(yao)(yao)(yao)產(chan)(chan)品(pin)(pin)(pin)的(de)生(sheng)(sheng)產(chan)(chan)轉化能力。

(記者 蔡鼎)

免責聲(sheng)明：本文內容與(yu)數據(ju)僅供參考，不構成(cheng)投資建議，使用前(qian)核實。據(ju)此(ci)操作，風險自(zi)擔(dan)。